Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, LIC

Quorum Review IRB Launches Live IRB Interface for Veeva Vault eTMF


SEATTLE, June 21, 2018 /PRNewswire/ -- Quorum Review IRB, the most preferred central IRB, today announced a live data sharing interface for Veeva Vault eTMF, a cloud application that enables all TMF processes and documents to be managed in one system, in real time, as they are executed. The first customers are now using an IRB interface with Veeva Vault eTMF from Veeva Systems.

Quorum Review IRB has been a Veeva Technology Partner since 2017.

The Quorum IRB integration facilitates seamless communication between customers of Veeva Vault eTMF and Quorum staff?without the need for access to the Quorum OnQ portal. The connection enables Quorum to push approval documents directly into client data systems and saves significant time for clinical trial teams. Shared clients benefit from reduced technology burden and increased accuracy with seamless data transfer into the eTMF platform.

"Quorum is proud to co-develop and launch IRB integration with Veeva Vault eTMF for multiple clients, including a top 10 pharma organization," said Cami Gearhart, CEO of Quorum. "Quorum continues to uphold the highest quality human subjects protections, while striving to go a step further as the partner of choice for agile and innovative independent ethics review services."

Last year, Quorum announced the availability of the first IRB-integrated electronic informed consent platform?Q Consenttm.

"These developments align with our customer promise of providing exceptional service through One-Touch Collaborationtm, and we look forward to offering more services and integrations to improve the study experience," continued Gearhart.

About Quorum

Quorum Review IRB is the most preferred central IRB. The Quorum difference is One-Touch Collaborationtm. Your research benefits from outstanding service experiences, dependable dedication to your studies, one contact, one study timeline, one stream of coordinated communications, plus coordinated IRB and IBC review. Quorum also offers an easy, fast, and affordable clinical research eConsent solution: Q Consent. Kinetiq, the research and technology consulting division of Quorum, moves your research forward with collaborative custom services.

Contact:
Scott Smith
Director of Marketing
Quorum Review IRB
(206) 448-4082
[email protected]

 

Quorum Review IRB is the most preferred central IRB. The Quorum difference is One-Touch Collaborationtm. Your research benefits from outstanding service experiences, dependable dedication to your studies, one contact, one study timeline, one stream of coordinated communications, plus coordinated IRB and IBC review. Quorum also offers an easy, fast, and affordable clinical research eConsent solution: Q Consent. (PRNewsfoto/Quorum Review IRB)

SOURCE Quorum Review IRB


These press releases may also interest you

at 07:30
Jushi Holdings Inc. ("Jushi" or the "Company") , a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, May...

at 07:25
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...

at 07:23
Straine Dental Management (SDM), a dentist-owned, dentist-led dental services organization (DSO), continues its national expansion with a strategic affiliation with Jolly Family Dental ? North Little Rock, Arkansas. SDM's entry into its 13th state...

at 07:20
Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD) in...

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...



News published on and distributed by: